HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuji Mikami Selected Research

Adenoma (Adenomas)

1/2013Adult nephroblastoma with predominant epithelial component: a differential diagnostic candidate of papillary renal cell carcinoma and metanephric adenoma-report of three cases.
5/2010Adrenocortical zonation in humans under normal and pathological conditions.
1/2008Combined gangliocytoma and prolactinoma of the pituitary gland.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuji Mikami Research Topics

Disease

71Neoplasms (Cancer)
06/2022 - 08/2004
33Renal Cell Carcinoma (Grawitz Tumor)
06/2022 - 07/2004
26Carcinoma (Carcinomatosis)
06/2022 - 08/2004
19Prostatic Neoplasms (Prostate Cancer)
07/2022 - 02/2010
17Neoplasm Metastasis (Metastasis)
01/2022 - 10/2008
10Urinary Bladder Neoplasms (Bladder Cancer)
05/2022 - 01/2010
8Adenocarcinoma
07/2022 - 01/2013
5Breast Neoplasms (Breast Cancer)
01/2022 - 06/2012
4Lymphatic Metastasis
06/2022 - 08/2004
4Disease Progression
10/2020 - 04/2013
3Non-Muscle Invasive Bladder Neoplasms
05/2022 - 01/2016
3Carcinoma in Situ
03/2021 - 03/2011
3Hypoxia (Hypoxemia)
06/2018 - 09/2006
3Kidney Neoplasms (Kidney Cancer)
02/2016 - 09/2008
3Carcinogenesis
07/2015 - 07/2004
3Adenoma (Adenomas)
01/2013 - 01/2008
2Retinoblastoma (Glioblastoma, Retinal)
01/2022 - 06/2012
2Hematuria
10/2021 - 05/2014
2Necrosis
12/2019 - 01/2008
2Cysts
12/2015 - 04/2014
1Testicular Neoplasms (Testicular Cancer)
12/2021
1Lung Neoplasms (Lung Cancer)
12/2021
1Urinary Retention
10/2021
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
01/2021

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2005
8Biological ProductsIBA
05/2022 - 12/2010
8PlatinumIBA
01/2022 - 11/2016
8Indicators and Reagents (Reagents)IBA
03/2021 - 08/2012
7Prostate-Specific Antigen (Semenogelase)IBA
07/2022 - 01/2014
6Biomarkers (Surrogate Marker)IBA
11/2021 - 10/2016
6LigandsIBA
11/2021 - 06/2014
5Cisplatin (Platino)FDA LinkGeneric
10/2020 - 01/2018
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 08/2004
5Protein Isoforms (Isoforms)IBA
04/2019 - 07/2004
4Tyrosine Kinase InhibitorsIBA
11/2021 - 08/2012
4Cadherins (E-Cadherin)IBA
11/2019 - 10/2011
4Sunitinib (Sutent)FDA Link
01/2017 - 05/2012
4heparanaseIBA
09/2016 - 08/2004
3AndrogensIBA
07/2022 - 01/2021
3C-Reactive ProteinIBA
08/2021 - 01/2018
3Pharmaceutical PreparationsIBA
01/2018 - 12/2006
3Matrix Metalloproteinases (MMPs)IBA
09/2016 - 02/2010
3Messenger RNA (mRNA)IBA
04/2015 - 09/2006
2Anaplastic Lymphoma KinaseIBA
06/2022 - 01/2021
2MucinsIBA
06/2022 - 10/2020
2taxaneIBA
01/2022 - 11/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2012
2Docetaxel (Taxotere)FDA Link
11/2021 - 05/2016
2Etoposide (VP 16)FDA LinkGeneric
11/2021 - 12/2019
2NivolumabIBA
08/2021 - 10/2019
2Mucin-1 (CA 15-3 Antigen)IBA
10/2020 - 04/2010
2enzalutamideIBA
10/2019 - 04/2016
2EverolimusFDA Link
12/2016 - 05/2012
2EnzymesIBA
09/2016 - 09/2014
2Phosphotransferases (Kinase)IBA
02/2016 - 02/2016
2tyrosine receptor (receptor, tyrosine)IBA
02/2016 - 02/2016
2SmokeIBA
07/2015 - 02/2010
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
07/2015 - 02/2010
2Small Interfering RNA (siRNA)IBA
07/2015 - 12/2010
2Contrast MediaIBA
04/2014 - 11/2011
2Capsules (Microcapsules)IBA
01/2014 - 08/2011
2Keratin-7 (Cytokeratin 7)IBA
01/2014 - 08/2011
2Angiotensin IIIBA
03/2012 - 02/2010
2Hormones (Hormone)IBA
02/2010 - 01/2008
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2006 - 08/2004
1alpha-methylacyl-CoA racemaseIBA
06/2022
1Phenobarbital (Luminal)FDA Link
05/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Androgen Receptors (Androgen Receptor)IBA
01/2022
1Androgen Receptor AntagonistsIBA
01/2022
1Radium-233IBA
01/2022
1Co-Repressor ProteinsIBA
01/2022
1AntigensIBA
12/2021
1cabazitaxelFDA Link
11/2021
1Type II DNA Topoisomerases (Topoisomerase II)IBA
11/2021
1cabozantinibIBA
11/2021
1Apoptosis Regulatory ProteinsIBA
08/2021
1MAP Kinase Kinase Kinase 1IBA
05/2021
1Abiraterone AcetateIBA
01/2021
1abirateroneIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
12/2020
1Amino Acid Transport System X-AG (Glutamate Transporter)IBA
10/2020
1Oncogene Proteins (Oncogene Protein)IBA
10/2020

Therapy/Procedure

29Therapeutics
07/2022 - 04/2008
11Nephroureterectomy
05/2022 - 02/2009
9Castration
07/2022 - 03/2012
9Drug Therapy (Chemotherapy)
01/2022 - 06/2012
4Radiotherapy
07/2022 - 07/2015
4Immunotherapy
10/2021 - 09/2014
4Lymph Node Excision (Lymph Node Dissection)
11/2014 - 02/2009
3Brachytherapy
07/2022 - 05/2014
3Aftercare (After-Treatment)
01/2018 - 01/2008
3Nephrectomy
09/2016 - 10/2008
2Prostatectomy (Retropubic Prostatectomy)
11/2021 - 11/2021
2Orchiectomy (Orchidectomy)
03/2020 - 01/2008
2Intravesical Administration
09/2014 - 01/2014
2Renal Dialysis (Hemodialysis)
11/2012 - 12/2011
1Decompression
01/2022
1General Anesthesia
12/2021
1Stem Cell Transplantation
01/2021